Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexxar + XRT for Relapsed Bulky NHL
NCT00490490Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Jan 2007
- Primary completion
- Jun 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tositumomab in non-Hodgkin lymphoma (NHL), sponsored by Stanford University. Started Jan 2007; status: terminated.
02
Drugs
tositumomab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00490490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490490.